Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 12/2006

01-12-2006

REG I Expression Predicts Long-term Survival among Locally Advanced Thoracic Squamous Cell Esophageal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy Followed by Esophagectomy

Authors: Satoru Motoyama, MD, Toshihiro Sugiyama, MD, Yasuharu Ueno, MD, Hiroshi Okamoto, MD, Shin Takasawa, MD, Hiroshi Nanjo, MD, Hitoshi Watanabe, Kiyotomi Maruyama, MD, Manabu Okuyama, MD, Jun-ichi Ogawa, MD

Published in: Annals of Surgical Oncology | Issue 12/2006

Login to get access

Abstract

Background

The prognosis for patients with locally advanced thoracic esophageal cancer is extremely unfavorable. We have been administering neoadjuvant chemoradiotherapy (CRT) followed by esophagectomy to these patients and studying whether REG I expression in untreated endoscopic biopsy specimens is predictive of patient responsiveness to CRT and/or survival after treatment.

Methods

Between 1992 and 2003, 47 patients with T4 (direct invasion of adjacent organs) thoracic esophageal cancers were administered neoadjuvant CRT followed by esophagectomy. REG I expression was assessed in untreated endoscopic biopsy specimens and correlated with clinical and histological responses and survival in 37 patients who had also undergone curative surgery.

Results

Among the 37 cases that received CRT followed by surgery, the therapeutic response rate for neoadjuvant CRT was 68%, and a complete histological response in resected specimens from the primary lesion was achieved in 8 (22%) patients. These clinical and histological responses to neoadjuvant CRT did not significantly correlate with survival, however. By contrast, 9 patients were judged REG-positive based on analysis of their untreated endoscopic biopsy specimens, and their cumulative survival rate was significantly higher than that of the 28 REG-negative patients (P = 0.0073). Univariate analysis showed REG I expression to be a prognostic factor (P = 0.0386) that increased the risk of death 8.4-fold.

Conclusions

Evaluation of REG I expression in untreated endoscopic biopsy specimens may provide a basis for new treatments of locally advanced thoracic squamous cell esophageal cancers.
Literature
1.
Abo S, Kitamura M, Hashimoto M, et al. Analysis of results of surgery performed over a 20-year period on 500 patients with cancer of the thoracic esophagus. Surg Today 1996; 26:77–82PubMedCrossRef
2.
Ando N, Ozawa S, Kitagawa Y, Shinozawa Y, Kitajima M. Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Ann Surg 2000; 232:225–32PubMedCrossRef
3.
Motoyama S, Saito R, Kamata S, et al. Survival advantage of using autologous blood transfusion during surgery for esophageal cancer. Surg Today 2002; 32:951–8PubMedCrossRef
4.
Ohtsu A, Boku N, Muro K, et al. Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus. J Clin Oncol 1999; 17:2915–21PubMed
5.
Hironaka S, Ohtsu A, Boku N, et al. Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T(2–3)N(any) M(0) squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 2003; 57:425–33PubMedCrossRef
6.
Terazono K, Yamamoto H, Takasawa S, Shiga K, Yonemura Y, Tochino Y, Okamoto H. A novel gene activated in regenerating islets. J Biol Chem 1988; 263:2111–4PubMed
7.
Watanabe T, Yonekura H, Yonemura Y, et al. Pancreatic beta-cell replication and amelioration of surgical diabetes by Reg protein. Proc Natl Acad Sci USA 1994; 91:3589–92PubMedCrossRef
8.
Bernard-Perrone FR, Renaud WP, Guy-Crottee OM, et al. Expression of REG protein during cell growth and differentiation of two human colon carcinoma cell lines. J Histochem Cytochem 1999; 47:863–70PubMed
9.
Christa L, Carrnot F, Simon MT, et al. HIP/PAP is an adhesion protein expressed in hepatocarcinoma, normal Paneth, and pancreatic cells. Am J Physiol 1996; 271:G993–G02PubMed
10.
Yonemura Y, Sakurai S, Yamamoto H, et al. REG gene expression is associated with the infiltrating growth of gastric carcinoma. Cancer 2003; 98:1394–00PubMedCrossRef
11.
Kadowaki Y, Ishihara S, Miyaoka Y, et al. Reg protein is overexpressed in gastric cancer cells, where it activates a signal transduction pathway that converges on ERK1/2 to stimulate growth. FEBS Lett 2002; 530:59–64PubMedCrossRef
12.
Japanese Society for Esophageal Diseases. Guidelines for the Clinical and Pathologic Studies on Carcinoma of the Esophagus. 9th edn. Kanehara Public Co, Tokyo. 1999
13.
Fujita H, Sueyoshi S, Tanaka T, et al. Prospective non-randomized trial comparing esophagectomy-followed-by-chemoradiotherapy versus chemoradiotherapy-followed-by-esophagectomy for T4 esophageal cancers. J Surg Oncol 2005; 90:209–19PubMedCrossRef
14.
Greer SE, Doodney PP, Sutton JE, Birkmeyer JD. Neoadjuvant chemoradiotherapy for esophageal carcinoma: a meta-analysis. Surgery 2005; 137:172–7PubMedCrossRef
15.
Chan ACW, Lee DWH, Griffith JF, et al. The clinical efficacy of neoadjuvant chemotherapy in squamous esophageal cancer: a prospective nonrandomized study of pulse and continuous-infusion regimens with cisplatin and 5-fluorouracil. Ann Surg Oncol 2002; 9:617–24PubMedCrossRef
16.
Takeuchi H, Ozawa S, Ando N, Kitagawa Y, Ueda M, Kitajima M. Cell-cycle regulators and the Ki-67 labeling index can predict the response to chemoradiotherapy and the survival of patients with locally advanced squamous cell carcinoma of the esophagus. Ann Surg Oncol 2003; 10:792–00PubMedCrossRef
17.
Kesler KA, Helft PR, Werner EA, et al. A retrospective analysis of locally advanced esophageal cancer patients treated with neoadjuvant chemoradiation therapy followed by surgery or surgery alone. Ann Thorac Surg 2005; 79:1116–21PubMedCrossRef
18.
Nakayama K, Kanzaki A, Terada K, et al. Prognostic value of the Cu-transporting ATPase in ovarian carcinoma patients receiving cisplatin-based chemotherapy. Clin Cancer Res 2004; 10:2804–11PubMedCrossRef
19.
Francis PJ, Southgate JL, Wilkin TJ, Bone AJ. Expression of an islet regeneration (reg) gene in isolated rat islets: effects of nutrient and non-nutrient growth factors. Diabetologia 1992; 35:238–42PubMedCrossRef
20.
Watanabe T, Yonekura H, Terazono K, Yamamoto H, Okamoto H. Complete nucleotide sequence of human reg gene and its expression in normal and tumoral tissues. J Biol Chem 1990; 265:7432–39PubMed
21.
Macadam RCA, Sarela AI, Farmey SM, Robinson PA, Markham AF, Guillou PJ. Death from early colorectal cancer is predicted by the presence of transcripts of the REG gene family. Br J Cancer 2000; 83:188–95PubMedCrossRef
22.
Harada K, Zen Y, Kanemori Y, et al. Human REG I gene is up-regulated in intrahepatic cholangiocarcinoma and its precursor lesions. Hepatology 2001; 33:1036–42PubMedCrossRef
23.
Geh JI, Crellin AM, Glynne-Jones R. Preoperative (neoadjuvant) chemoradiotherapy in oesophageal cancer. Br J Surg 2001; 88:338–356PubMedCrossRef
24.
Slater MS, Holland J, Faigel DO, Sheppard BC, Deveney CW. Does neoadjuvant chemoradiation downstage esophageal carcinoma? Am J Surg 2001; 181:440–4PubMedCrossRef
25.
Ikeda K, Ishida K, Sato N, et al. Chemoradiotherapy followed by surgery for thoracic esophageal cancer potentially or actually involving adjacent organs. Dis Esophagus 2001; 14:197–01PubMedCrossRef
Metadata
Title
REG I Expression Predicts Long-term Survival among Locally Advanced Thoracic Squamous Cell Esophageal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy Followed by Esophagectomy
Authors
Satoru Motoyama, MD
Toshihiro Sugiyama, MD
Yasuharu Ueno, MD
Hiroshi Okamoto, MD
Shin Takasawa, MD
Hiroshi Nanjo, MD
Hitoshi Watanabe
Kiyotomi Maruyama, MD
Manabu Okuyama, MD
Jun-ichi Ogawa, MD
Publication date
01-12-2006
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 12/2006
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-006-9075-z

Other articles of this Issue 12/2006

Annals of Surgical Oncology 12/2006 Go to the issue

OriginalPaper

Second Hepatectomy for Recurrent Colorectal Liver Metastasis: Analysis of Preoperative Prognostic Factors

OriginalPaper

Patient Satisfaction and Aesthetic Results After Pedicled Transverse Rectus Abdominis Muscle Flap for Breast Reconstruction

OriginalPaper

Hepatectomy for Peripheral Cholangiocarcinoma in Elderly Patients

OriginalPaper

Immunohistochemical Expression of p16INK4A, Ki-67, and Mcm2 Proteins in Gastrointestinal Stromal Tumors: Prognostic Implications and Correlations with Risk Stratification of NIH Consensus Criteria

OriginalPaper

Nuclear Translocation of β-Catenin Protein but Absence of β-Catenin and APC Mutation in Gastrointestinal Carcinoid Tumor

OriginalPaper

Sonographically Guided Fine Needle Aspiration with Rapid Parathyroid Hormone Assay